Target intelligence / Profile preview

ErbB4 receptor tyrosine kinase (ERBB4)

Target
ERBB4
Molecular classification
Receptor, Type I RTK, EGFR/ErbB family, Receptor tyrosine kinase
01

Overview

ErbB4 receptor tyrosine kinase (ERBB4) is a member of the epidermal growth factor receptor (EGFR/ErbB) family of type I receptor tyrosine kinases. It binds to neuregulins (NRG1, NRG2, NRG3, NRG4), as well as EGF family ligands such as betacellulin (BTC), epiregulin (EREG), and heparin-binding EGF-like growth factor (HBEGF). Ligand binding induces homo-/heterodimerization with other ErbB receptors, leading to autophosphorylation of cytoplasmic tyrosines and activation of intracellular signaling cascades including PI3K-AKT and Ras-MAPK pathways. ERBB4 is essential for normal development of the heart, central nervous system, and mammary gland, and regulates gene transcription, cell proliferation, differentiation, migration, and apoptosis. Mutations or aberrant ERBB4 signaling have been implicated in various cancers, amyotrophic lateral sclerosis, schizophrenia, and frontotemporal dementia. Alternative splicing produces multiple isoforms with distinct properties. Can signal independently of its intrinsic kinase activity in certain contexts. EGFR is an important paralog.

Other names
HER4erb-b2 receptor tyrosine kinase 4
02

Mechanism of action

Tyrosine kinase inhibition; modulation of downstream signaling pathways (PI3K-AKT, Ras-MAPK); regulation of gene expression

03

Biological functions

Signal transductionCell proliferationCell differentiationApoptosisRegulation of gene transcriptionCardiac muscle differentiationNeural crest cell migrationAxon guidanceLactationCell migration
04

Disease associations

CancerMelanomaLung adenocarcinomaMedulloblastomaAmyotrophic lateral sclerosis type 19Familial ALS19SchizophreniaFrontotemporal dementia

Beyond the preview

Go deeper on ErbB4 receptor tyrosine kinase (ERBB4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ErbB4 receptor tyrosine kinase (ERBB4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call